These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1646997)

  • 21. Potent bombesin receptor antagonists distinguish receptor subtypes.
    von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
    Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
    Koppán M; Halmos G; Arencibia JM; Lamharzi N; Schally AV
    Cancer; 1998 Oct; 83(7):1335-43. PubMed ID: 9762934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
    Ciomei M; Pastori W; Pastori A; de Castiglione R; Gozzini L; Corradi F
    Anticancer Res; 1993; 13(1):75-9. PubMed ID: 8386497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists.
    Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW
    Synapse; 1988; 2(3):282-7. PubMed ID: 2463692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
    Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat.
    Coy DH; Mungan Z; Rossowski WJ; Cheng BL; Lin JT; Mrozinski JE; Jensen RT
    Peptides; 1992; 13(4):775-81. PubMed ID: 1279632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
    Cai RZ; Reile H; Armatis P; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
    Kado-Fong H; Malfroy B
    J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
    Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
    J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
    Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
    Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
    Carney DN; Cuttitta F; Moody TW; Minna JD
    Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line.
    Trepel JB; Moyer JD; Cuttitta F; Frucht H; Coy DH; Natale RB; Mulshine JL; Jensen RT; Sausville EA
    Biochem Biophys Res Commun; 1988 Nov; 156(3):1383-9. PubMed ID: 2847733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
    Moody TW; Staley J; Zia F; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
    Mantey S; Frucht H; Coy DH; Jensen RT
    Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
    Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
    Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory cyclic analogues and chlorambucil derivatives of bombesin-like peptides.
    Knight M; Takahashi K; Chandrasekhar B; Geblaoui AZ; Jensen RT; Strader D; Moody TW
    Peptides; 1995; 16(6):1109-15. PubMed ID: 8532595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bombesin receptor antagonists block the effects of exogenous bombesin but not of nutrients on food intake.
    Flynn FW
    Physiol Behav; 1997 Oct; 62(4):791-8. PubMed ID: 9284499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.